title: Determinants of hospital survival after cardiac transplantation.
abstract: To identify the preoperative factors that influence hospital survival after transplantation we analyzed our consecutive experience of 183 transplantations in 179 patients over a 10-year period. There were 151 male and 29 female transplant recipients ranging in age from 10 days to 70 years (mean, 48 +/- 1 years). Diagnoses included coronary disease in 110 patients, cardiomyopathy in 55 patients, valvular disease in 6 patients, and congenital heart disease in 9 patients. Seventy-seven had undergone a previous cardiac operation, and 30 patients required preoperative mechanical support. Forty patients received hearts from donors who were 40 years old or older (range, 40 to 62 years). Ischemic time was greater than 240 minutes in 32 cases, and pulmonary vascular resistance was greater than 3 Wood units in 40 patients (range, 3.1 to 10.0 Wood units). Cyclosporine induction was used in 52 patients, whereas 128 recipients received polyclonal antibody prophylaxis. There were 25 hospital deaths. Recipient diagnosis, use of mechanical support, donor age, and the immune suppression protocol were related to hospital survival according to univariate analysis. Using multiple logistic regression, only the method of immune suppression induction and the use of mechanical assists were significant independent determinants of survival. In conclusion, we believe that extended ischemic times and donor age do not adversely affect the early success of transplantation, whereas induction with immune globulin may reduce early mortality. Patients requiring mechanical support before transplantation continue to be a challenge.
authors.affiliation: University of Ottawa Heart Institute, Division of Cardiac Surgery, Ottawa Civic Hospital, Canada.
authors.forename: M
authors.initials: M
authors.lastname: Ibrahim
authors.forename: R G
authors.initials: RG
authors.lastname: Masters
authors.forename: P J
authors.initials: PJ
authors.lastname: Hendry
authors.forename: R A
authors.initials: RA
authors.lastname: Davies
authors.forename: S
authors.initials: S
authors.lastname: Smith
authors.forename: C
authors.initials: C
authors.lastname: Struthers
authors.forename: V M
authors.initials: VM
authors.lastname: Walley
authors.forename: W J
authors.initials: WJ
authors.lastname: Keon
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D009202:Cardiomyopathies / Q000401:mortality / Q000601:surgery*; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D003327:Coronary Disease / Q000401:mortality / Q000601:surgery*; D005260:Female; D006330:Heart Defects, Congenital / Q000401:mortality / Q000601:surgery*; D016027:Heart Transplantation; D006349:Heart Valve Diseases / Q000401:mortality / Q000601:surgery*; D017052:Hospital Mortality; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D011183:Postoperative Complications / Q000453:epidemiology* / Q000503:physiopathology / Q000628:therapy; D011300:Preoperative Care; D011652:Pulmonary Circulation; D012086:Reoperation; D012307:Risk Factors; D012737:Sex Factors; D015996:Survival Rate; D013997:Time Factors; D014019:Tissue Donors; D014655:Vascular Resistance